$1M Healthcare Innovation Award to Fight Child Mortality
GlaxoSmithKline and Save the Children have launched a fund totalling $1,000,000 to reward organisations practicing innovative approaches for reducing under-5 child mortality.
StepChange Innovations blog covers innovations and issues in pharma
US Supreme Court stops patenting of human genes
The US Supreme Court unanimously ruled that human genes cannot be patented, drawing a red line between naturally occurring DNA sequences and artificial genes created in the lab.
The Open Innovation Revolution
Open innovation is today a modern management tool within corporate innovation management - in the last decade open innovation has become an important extension to the classical innovation approach, to improve the success rate of the innovation pipeline.
Big pharma´s patent wars in India
The Indian Supreme court has rejected a key patent of Novartis for their cancer drug Glivec. The verdict adds to a series of strikes against multinational pharmaceutical companies to gain patent rights in India, potentially one of the biggest pharmaceutical markets in the world.
Inventor Jack Andraka
Teenager invents cheap and highly selective cancer diagnostics test
15 year old teenager Jack Andraka invented a pancreatic cancer test many times faster, considerably cheaper and more accurate than the current testing standard in today’s standard cancer diagnostics.
CRAMS outsourcing in pharmaceutical and chemical research and manufacturing, part III.
In this article we discuss CRO offshore outsourcing in the chemical and pharmaceutical industry, especially what drives outsourcing, the process for vendor selection, typical problems in CRO outsouring, and CRO Offshore Outsourcing to China and India.
CRAMS outsourcing in pharmaceutical and chemical research and manufacturing, part II.
We will outline in the second part of this article series how big is the business of Contract research and manufacturing services (CRAMS) in the pharmaceutical, bio-technological and chemical industry.
CRAMS outsourcing in pharmaceutical and chemical research and manufacturing Part I.
Contract research and manufacturing services (CRAMS) in the pharmaceutical, bio-technological and chemical industry is massive, a multi-billion dollar business. We will outline in this article how big is this business, what drives this business and what are the implications for enterprises and for the society ? We will outline in this article the political and macro-economical implications of outsourcing.
A New Technique that will Transform Epigenetics Research
new technique that will transform epigenetics research by quantitative sequencing
Blocking HIV’s Attack
scientists have rid one man of HIV by preventing the virus from entering certain immune cells